Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia ; volume:22 ; number:1 ; day:16 ; month:8 ; year:2022 ; pages:1-11 ; date:12.2022
BMC cancer ; 22, Heft 1 (16.8.2022), 1-11, 12.2022

Creator: Bai, Lu
Zhang, Yong-zhan
Yan, Chen-hua
Wang, Yu
Xu, Lan-ping
Zhang, Xiao-hui
Zhang, Le-ping
Huang, Xiao-jun
Cheng, Yi-fei

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12885-022-09978-3

URN: urn:nbn:de:101:1-2022110322380377068948

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:32 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bai, Lu
Zhang, Yong-zhan
Yan, Chen-hua
Wang, Yu
Xu, Lan-ping
Zhang, Xiao-hui
Zhang, Le-ping
Huang, Xiao-jun
Cheng, Yi-fei
SpringerLink (Online service)

Other Objects (12)

Hochschulschrift

The role of EZH2 in CDK6 bockade-mediated differentiation in MLL-rearranged acute myeloid leukaemia

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML

The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia

RNA binding proteins in MLL-rearranged leukemia

Hochschulschrift

Using genome editing to model MLL rearranged leukemias

Molecular pathogenesis of disease progression in MLL-rearranged AML

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia

Hochschulschrift

The role of EZH2 in CDK6 bockade-mediated differentiation in MLL-rearranged acute myeloid leukaemia

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML

The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia

RNA binding proteins in MLL-rearranged leukemia

Hochschulschrift

Using genome editing to model MLL rearranged leukemias

Molecular pathogenesis of disease progression in MLL-rearranged AML

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia

Hochschulschrift

The role of EZH2 in CDK6 bockade-mediated differentiation in MLL-rearranged acute myeloid leukaemia

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML

The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia

RNA binding proteins in MLL-rearranged leukemia

Hochschulschrift

Using genome editing to model MLL rearranged leukemias

Molecular pathogenesis of disease progression in MLL-rearranged AML

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The role of EZH2 in CDK6 bockade-mediated differentiation in MLL-rearranged acute myeloid leukaemia

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML

The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia

RNA binding proteins in MLL-rearranged leukemia

Using genome editing to model MLL rearranged leukemias

Molecular pathogenesis of disease progression in MLL-rearranged AML

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia

The role of EZH2 in CDK6 bockade-mediated differentiation in MLL-rearranged acute myeloid leukaemia

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML

The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia

RNA binding proteins in MLL-rearranged leukemia

Using genome editing to model MLL rearranged leukemias

Molecular pathogenesis of disease progression in MLL-rearranged AML

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia

The role of EZH2 in CDK6 bockade-mediated differentiation in MLL-rearranged acute myeloid leukaemia

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML

The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia

RNA binding proteins in MLL-rearranged leukemia

Using genome editing to model MLL rearranged leukemias

Molecular pathogenesis of disease progression in MLL-rearranged AML

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia

Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia

Related objects

Reset password